Compare PRSO & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRSO | PAVM |
|---|---|---|
| Founded | 2008 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.8M | 9.3M |
| IPO Year | 2001 | 2016 |
| Metric | PRSO | PAVM |
|---|---|---|
| Price | $0.98 | $0.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $3.00 | ★ $20.00 |
| AVG Volume (30 Days) | ★ 932.8K | 481.5K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,001,000.00 | $29,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23.70 | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.15 | N/A |
| 52 Week Low | $0.52 | $0.30 |
| 52 Week High | $2.37 | $0.98 |
| Indicator | PRSO | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 45.70 | 46.56 |
| Support Level | $0.92 | $0.31 |
| Resistance Level | $1.05 | $0.39 |
| Average True Range (ATR) | 0.07 | 0.03 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 70.87 | 40.45 |
Peraso Inc is a fabless semiconductor company focused on the development and sale of: i) millimeter wavelength wireless technology, or mmWave, semiconductor devices and antenna modules based on its proprietary semiconductor devices and ii) performance of non-recurring engineering, or NRE, services and licensing of intellectual property, or IP. The company's primary focus is the development of mmWave, which is generally described as the frequency band from 24 Gigahertz, or GHz, to 300 GHz. Geographically the company generates revenue from the United States, Hong Kong, Taiwan, and the Rest of the World.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.